Brachydactyly type C
brak-ee-DAK-tuh-lee type C
Also known as: BDC, Short finger syndrome type C
At a Glance
What is Brachydactyly type C?
Brachydactyly type C is a genetic condition characterized by abnormally short fingers. It primarily affects the bones of the hands, leading to shortened metacarpals and phalanges. This condition is caused by mutations in specific genes, such as GDF5, that are involved in bone development. Over time, individuals may experience difficulty with fine motor skills due to the altered structure of their hands. Early symptoms include visibly short fingers and potential misalignment of the joints. As the individual grows, these symptoms may become more pronounced, potentially affecting hand function. Early diagnosis is crucial to manage any functional impairments and to provide genetic counseling to families. The condition can impact family life, especially if multiple members are affected, as it may require adaptations in daily activities. The prognosis for individuals with brachydactyly type C is generally good, as it does not typically affect overall health or life expectancy. Daily life may involve challenges with tasks requiring precise hand movements, but many individuals adapt well. Treatment options, such as surgery, are available to improve hand function if necessary. Supportive therapies, including occupational therapy, can also help individuals develop strategies to manage daily tasks effectively.
Medical Definition
Brachydactyly type C is a congenital limb malformation characterized by shortening of the middle phalanges and metacarpals, particularly affecting the second and fifth fingers. Pathologically, it involves mutations in genes such as GDF5, which play a role in chondrogenesis and bone growth. Histologically, affected bones may show abnormal growth patterns due to disrupted signaling pathways. It is classified under the broader category of brachydactyly, with specific phenotypic features distinguishing type C from other types. Epidemiologically, it is a rare disorder with autosomal dominant inheritance, though the exact prevalence is not well-defined. The disease course is generally stable, with symptoms present from birth and no significant progression over time.
Brachydactyly type C Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Shortened fingers are a hallmark of brachydactyly type C, presenting as abnormally short bones in the fingers. This is caused by mutations affecting bone growth, particularly in the phalanges and metacarpals. Over time, the shortening may become more pronounced, especially during growth spurts. This can affect the patient's ability to perform tasks requiring fine motor skills, but occupational therapy can help improve function.
Symphalangism manifests as the fusion of finger joints, leading to limited finger movement. It results from abnormal bone development where the joints fail to separate properly. As the individual grows, joint stiffness may increase, further restricting hand function. Daily activities such as gripping or typing can be challenging, but physical therapy can aid in maintaining joint mobility.
Deviation of fingers occurs when fingers are angled or curved, often noticeable at birth. This is due to uneven growth rates of the finger bones, influenced by genetic mutations. The deviation can become more apparent with age, particularly if not addressed early. It can impact the ability to grasp objects, but corrective surgery may be considered to improve hand alignment.
Common
Hypoplastic thumbs are underdeveloped thumbs that may be smaller or less functional than normal. This condition arises from genetic disruptions affecting thumb development during fetal growth. As the child grows, the thumb may not fully develop, impacting hand dexterity. Adaptive devices and surgical interventions can enhance thumb function and overall hand use.
Limited hand function is characterized by reduced ability to perform tasks requiring hand strength and dexterity. This results from the combination of shortened fingers, joint fusion, and other structural anomalies. Over time, the limitations may become more pronounced, affecting daily activities like writing or buttoning clothes. Rehabilitation programs focusing on strength and coordination can help mitigate these challenges.
Joint stiffness in the fingers can lead to reduced flexibility and movement. It is caused by abnormal joint formation and fusion, common in brachydactyly type C. As the individual ages, stiffness may worsen, particularly if not actively managed. Regular stretching exercises and physical therapy can help maintain joint mobility and reduce stiffness.
Less Common
Nail dysplasia is the abnormal development of fingernails, which may appear misshapen or brittle. This occurs due to disruptions in the nail matrix, often associated with underlying bone abnormalities. Over time, nail appearance may worsen, potentially leading to discomfort or cosmetic concerns. Proper nail care and protective measures can help manage this condition.
Carpal bone anomalies involve irregularities in the wrist bones, which may be detected via imaging. These anomalies are due to genetic mutations affecting bone development in the wrist area. As the individual grows, these anomalies may contribute to wrist instability or discomfort. Orthopedic evaluation and supportive interventions can aid in managing symptoms and improving wrist function.
What Causes Brachydactyly type C?
Brachydactyly type C is primarily caused by mutations in the GDF5 gene, located on chromosome 20q11.2, and the CDMP1 gene, located on chromosome 12q24. The GDF5 gene encodes a growth differentiation factor involved in the development of bones and joints, while CDMP1 encodes a cartilage-derived morphogenetic protein. Mutations in these genes often result in frameshift or missense mutations that alter the protein's structure, leading to a loss of function. These mutations disrupt the signaling pathways critical for chondrogenesis, the process by which cartilage is formed. The impaired signaling affects the differentiation and proliferation of chondrocytes, the cells responsible for cartilage production. This cellular dysfunction leads to abnormal cartilage formation and subsequent bone development issues. The disruption in cartilage formation can trigger a localized inflammatory response, although neuroinflammation is not a primary feature of this condition. The immune response may exacerbate tissue degeneration, particularly in the developing phalanges. As a result, the affected digits exhibit shortened and malformed bones, characteristic of brachydactyly type C. The pattern of symptoms, such as shortened middle phalanges and hyperphalangism, arises due to the specific roles of GDF5 and CDMP1 in digit formation. Variability in disease severity among patients can be attributed to the specific nature of the mutation and potential involvement of modifier genes. Additionally, environmental factors and genetic background may influence the phenotypic expression. The precise molecular mechanisms by which these mutations lead to the observed phenotypic variability remain an area of active research.
How is Brachydactyly type C Diagnosed?
Typical age of diagnosis: Brachydactyly type C is typically diagnosed in early childhood when characteristic hand deformities become apparent, often during routine pediatric check-ups or when parents notice abnormalities in finger length and shape.
The clinician looks for shortened middle phalanges and variable shortening of the metacarpals, particularly affecting the index and middle fingers. Family history is crucial as brachydactyly type C is inherited in an autosomal dominant pattern. Physical examination reveals brachydactyly with possible clinodactyly and hyperphalangy. This step helps differentiate brachydactyly type C from other hand malformations.
X-rays of the hands are the primary imaging modality used to assess bone structure. Specific abnormalities include shortened middle phalanges and metacarpals, often with cone-shaped epiphyses. These findings confirm the diagnosis by matching the characteristic pattern of bone shortening. Imaging helps exclude other conditions like symbrachydactyly or isolated clinodactyly.
Routine laboratory tests are not typically required for diagnosis, but may include basic metabolic panels to rule out other systemic conditions. Biomarkers are not specific for brachydactyly type C. Abnormal results are not expected in isolated cases, but may guide further investigation if syndromic features are present. Laboratory tests are generally supportive rather than diagnostic.
Genetic testing focuses on sequencing the GDF5 gene and other related genes like CDMP1. Mutations such as frameshift or missense mutations are commonly found. Positive results confirm the diagnosis and provide a basis for genetic counseling. Genetic testing informs family planning and assesses the risk of transmission to offspring.
Brachydactyly type C Treatment Options
Non-steroidal anti-inflammatory drugs (NSAIDs) are used to manage pain associated with joint deformities. They work by inhibiting cyclooxygenase enzymes, reducing inflammation and pain. Common drugs include ibuprofen and naproxen. Clinical evidence supports their use for symptomatic relief, but they do not alter disease progression. Side effects may include gastrointestinal discomfort and increased bleeding risk.
Hand therapy involves exercises and splinting to improve hand function and dexterity. The goal is to enhance range of motion and strength in affected fingers. Sessions are typically conducted 2-3 times per week for several months. Measurable outcomes include improved grip strength and finger mobility. Long-term benefits include better hand function and reduced disability.
Surgery is indicated for severe functional impairment or cosmetic concerns. The procedure involves removing a wedge of bone to correct angular deformities. Expected benefits include improved hand function and appearance. Surgical risks include infection, nerve damage, and nonunion of bones. Post-operative care requires immobilization and rehabilitation to ensure optimal recovery.
The care team includes orthopedic specialists, genetic counselors, and occupational therapists. Interventions focus on maximizing function and providing adaptive devices if necessary. Psychosocial support strategies address emotional and social challenges faced by patients and families. Family education covers genetic aspects and management strategies. Long-term monitoring involves regular follow-ups to assess growth and development.
When to See a Doctor for Brachydactyly type C
- Severe pain in the fingers or hands — this could indicate a complication requiring immediate medical attention.
- Sudden loss of function in the hand — this may suggest nerve or vascular involvement that needs urgent evaluation.
- Signs of infection such as redness, swelling, or fever — these symptoms require prompt treatment to prevent further complications.
- Persistent discomfort or stiffness in the fingers — this may indicate worsening of the condition and should be assessed by a healthcare provider.
- Noticeable changes in finger shape or size over time — this could suggest progression of the condition and warrants a medical review.
- Difficulty performing daily tasks due to hand function — this impacts quality of life and should be discussed with a doctor for management options.
- Mild discomfort in the fingers — monitor for any changes in severity or frequency and consult a doctor if it worsens.
- Occasional stiffness in the fingers — keep track of when it occurs and if it affects daily activities, consider discussing with a healthcare provider.
Brachydactyly type C — Frequently Asked Questions
Is this condition hereditary?
Brachydactyly type C is typically inherited in an autosomal dominant pattern, meaning one copy of the altered gene is sufficient to cause the disorder. There is a 50% chance of passing the condition to offspring if one parent is affected. De novo mutations can occur, leading to the condition in individuals with no family history. Carriers of the gene may or may not show symptoms, depending on the mutation's expressivity. Genetic counseling is recommended for affected individuals and their families to understand inheritance patterns and risks.
What is the life expectancy for someone with this condition?
Life expectancy for individuals with brachydactyly type C is generally normal, as the condition primarily affects the hands without systemic involvement. Prognosis is not significantly impacted by age of onset. Factors such as access to appropriate medical care and management of symptoms can improve outcomes. Mortality is not directly associated with brachydactyly type C, as it does not typically involve life-threatening complications. Treatment focuses on improving hand function and quality of life rather than survival.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis of brachydactyly type C involves a combination of clinical evaluation, family history assessment, and genetic testing. The time from first symptoms to diagnosis can vary, but it often takes several months to a year. Specialists such as geneticists and orthopedic surgeons are typically consulted. Delayed diagnosis may occur due to the rarity of the condition and its overlap with other hand malformations. Genetic testing confirming mutations in specific genes, such as GDF5, provides a definitive diagnosis.
Are there any new treatments or clinical trials available?
Current research is exploring the role of gene therapy and novel pharmacological approaches in treating brachydactyly type C. Clinical trials may be available and can be found on ClinicalTrials.gov by searching for the condition. Patients should discuss potential participation in trials with their healthcare provider. It is important to ask about the risks, benefits, and eligibility criteria for new treatments. While promising, these treatments may still be several years away from being widely available.
How does this condition affect daily life and activities?
Brachydactyly type C can impact hand mobility and dexterity, affecting self-care and daily tasks. Educational adaptations may be necessary for children to accommodate handwriting and fine motor skills. Social and emotional challenges can arise from visible differences and functional limitations. The condition can place a burden on families, requiring support and resources. Occupational therapy and adaptive devices can significantly improve daily functioning and quality of life.
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Brachydactyly type C.
Burgess RC · J Hand Surg Am · 2001 · PMID: 11172365
- 2.A GDF5 frameshift mutation segregating with Grebe type chondrodysplasia and brachydactyly type C+ in a 6 generations family: Clinical report and mini review.
Faryal S, Farooq M, Abdullah U et al. · Eur J Med Genet · 2021 · PMID: 33872773
- 3.Brachydactyly type C caused by a homozygous missense mutation in the prodomain of CDMP1.
Schwabe GC, Türkmen S, Leschik G et al. · Am J Med Genet A · 2004 · PMID: 14735582
- 4.The mutational spectrum of brachydactyly type C.
Everman DB, Bartels CF, Yang Y et al. · Am J Med Genet · 2002 · PMID: 12357473
- 5.Genetics, Clinical Presentation, Radiological Features, and Midterm Outcome of Closing Wedge Osteotomy in Children With Brachydactyly Type C.
Al-Qattan MM · Ann Plast Surg · 2022 · PMID: 35502951
- 6.Frameshift Mutation in a Chinese Patient with Brachydactyly Type C Involving the Third Metacarpal: A Case Report.
Li Q, Bai F, Chen S · Orthop Surg · 2022 · PMID: 35819086
- 7.Brachydactyly type C gene maps to human chromsome 12q24.
Polymeropoulos MH, Ide SE, Magyari T et al. · Genomics · 1996 · PMID: 8954778
- 8.[Brachydactyly type C due to a nonsense mutation in the GDF5 gene].
Travieso-Suárez L, Pereda A, Pozo-Román J et al. · An Pediatr (Engl Ed) · 2018 · PMID: 28391997
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-04-26